|
CA2770355A1
|
|
Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease
|
|
WO2011022074A1
|
|
Riboflavin based aerosol and use as placebo in trials
|
|
RU2535056C2
|
|
Methods of treating pulmonary bacterial infection with application of fluoroquinolones
|
|
US2010158957A1
|
|
Aerosolized fluoroquinolones and uses thereof
|
|
BRPI0920026A2
|
|
method of treatment of pulmonary infection, pharmaceutical composition and its uses.
|
|
CN102325532A
|
|
Inhalation of levofloxacin for reducing lung inflammation
|
|
EP2155776A2
|
|
Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
|
|
US2008318957A1
|
|
Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
|
|
ZA200710745B
|
|
Aerosolized fluoroquinolones and uses thereof
|
|
US2008076741A1
|
|
Enhancement of tigecycline potency using efflux pump inhibitors
|
|
US2006276483A1
|
|
Aerosolized fluoroquinolones and uses thereof
|
|
CN104173323A
|
|
Aerosolized fluoroquinolones and uses thereof
|
|
AU2005245962A1
|
|
Bacterial efflux pump inhibitors and methods of treating bacterial infections
|
|
CA2559208A1
|
|
Use and administration of bacterial efflux pump inhibitors
|
